Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification
Dong Ho Lee
Clin Mol Hepatol. 2017;23(4):290-301.   Published online 2017 Oct 10     DOI: https://doi.org/10.3350/cmh.2017.0042
Citations to this article as recorded by Crossref logo
Circulating extracellular vesicles are associated with pathophysiological condition including metabolic syndrome-related dysmetabolism in children and adolescents with obesity
Yoshinao Kobayashi, Akiko Eguchi, Koshi Imami, Mina Tempaku, Kiyora Izuoka, Takafumi Takase, Keigo Kainuma, Mizuho Nagao, Noriko Furuta, Motoh Iwasa, Hayato Nakagawa, Takao Fujisawa, Kenji Togashi
Journal of Molecular Medicine.2024; 102(1): 23.     CrossRef
Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities, and Management of Non-alcoholic Fatty Liver Disorder
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin
Current Drug Therapy.2024; 19(1): 20.     CrossRef
Associations of serum uric acid levels and anthropometric parameters with non-alcoholic fatty liver disease in healthy individuals: innovative insights from a cross-sectional study
Ahmet Aydin, Sabin Goktas Aydin
Current Medical Research and Opinion.2024; 40(2): 209.     CrossRef
Machine learning prediction of hepatic steatosis using body composition parameters: A UK Biobank Study
Delbert Almerick T. Boncan, Yan Yu, Miaoru Zhang, Jie Lian, Varut Vardhanabhuti
npj Aging.2024;[Epub]     CrossRef
The association of metabolic dysfunction-associated steatotic liver disease (MASLD) with the risk of myocardial infarction: a systematic review and meta-analysis
Qiong Lv, Huashan Zhao
Annals of Medicine.2024;[Epub]     CrossRef
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes
Sabhita Shabir Shaikh, Fakhar Ali Qazi-Arisar, Saba Nafay, Sidra Zaheer, Hafeezullah Shaikh, Zahid Azam
World Journal of Hepatology.2024; 16(1): 54.     CrossRef
Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies
Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, Mohammad Zulqurnain Haider, Mohammed Imad Malki, Abdel-Naser Elzouki
Frontiers in Medicine.2024;[Epub]     CrossRef
Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters
Jeongin Yoo, Ijin Joo, Sun Kyung Jeon, Junghoan Park, Soon Ho Yoon
European Radiology.2024;[Epub]     CrossRef
Improving data adequacy of ultrasonography reports for non-alcoholic fatty liver disease (NAFLD) through a national structured template
Seyedeh Nahid Seyedhasani, Sara Dorri, Omid Pournik, Seyed Ali Alamdaran, Saeid Eslami
Acta Radiologica.2023; 64(2): 473.     CrossRef
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
Jingxuan Quek, Kai En Chan, Zhen Yu Wong, Caitlyn Tan, Bryan Tan, Wen Hui Lim, Darren Jun Hao Tan, Ansel Shao Pin Tang, Phoebe Tay, Jieling Xiao, Jie Ning Yong, Rebecca Wenling Zeng, Nicholas W S Chew, Benjamin Nah, Anand Kulkarni, Mohammad Shadab Siddiqu
The Lancet Gastroenterology & Hepatology.2023; 8(1): 20.     CrossRef
Incidence and Impact of Non‐alcoholic Fatty Liver Disease (NAFLD) in Patients with Adenocarcinoma of the Esophagus Treated with Curative Intent
John V. Reynolds, Noel E. Donlon, Jessie A. Elliott, Brendan Moran, Hugo Temperley, Tim S. Nugent, Maria Davern, Sinead King, Melissa Conroy, Joanne Lysaght, Narayanasamy Ravi, Carmel Ryan, Stephen Finn, Suzanne Norris, Clare L. Donohoe
World Journal of Surgery.2023; 47(1): 227.     CrossRef
Direct activation of the fibroblast growth factor-21 pathway in overweight and obese cats
Emily J. Brinker, T. Jordan Towns, Rie Watanabe, Xiaolei Ma, Adil Bashir, Robert C. Cole, Xu Wang, Emily C. Graff
Frontiers in Veterinary Science.2023;[Epub]     CrossRef
Prevalence and impact of non-alcoholic fatty liver disease in patients with papillary thyroid carcinoma
Renyi Xiao, Chunjue Ni, Yefeng Cai, Yili Zhou, Xiaohua Gong, Keyue Xie, Jie You
Endocrine.2023; 80(3): 619.     CrossRef
Colonic permeability is increased in non-cirrhotic patients with nonalcoholic fatty liver disease
Toon J.I. De Munck, Pauline Verhaegh, Corinne Spooren, Zlatan Mujagic, Tobias Wienhold, Daisy Jonkers, Ad A.M. Masclee, Ger H. Koek, Jef Verbeek
Digestive and Liver Disease.2023; 55(5): 614.     CrossRef
Improving diagnostic accuracy of ultrasound texture features in detecting and quantifying hepatic steatosis using various beamforming sound speeds
Kibo Nam, Mehnoosh Torkzaban, Dina Halegoua-DeMarzio, Corinne E Wessner, Andrej Lyshchik
Physics in Medicine & Biology.2023; 68(4): 04NT02.     CrossRef
Evaluation of Artificial Intelligence-Calculated Hepatorenal Index for Diagnosing Mild and Moderate Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease
Zita Zsombor, Aladár D. Rónaszéki, Barbara Csongrády, Róbert Stollmayer, Bettina K. Budai, Anikó Folhoffer, Ildikó Kalina, Gabriella Győri, Viktor Bérczi, Pál Maurovich-Horvat, Krisztina Hagymási, Pál Novák Kaposi
Medicina.2023; 59(3): 469.     CrossRef
Correlation between CT Abdominal Anthropometric Measurements and Liver Density in Individuals with Non-Alcoholic Fatty Liver Disease
Dragoș Constantin Cucoranu, Marian Pop, Raluca Niculescu, Vlad Vunvulea, Irina-Bianca Kosovski, Radu-Ovidiu Togănel, Eliza Russu, Adrian Vasile Mureșan, Răzvan-Andrei Licu, Anca Bacârea
Medicina.2023; 59(3): 500.     CrossRef
Administrative coding for non-alcoholic fatty liver disease is accurate in Swedish patients
Hanne Åström, Axel Wester, Hannes Hagström
Scandinavian Journal of Gastroenterology.2023; 58(8): 931.     CrossRef
CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease
Ha Neul Kim, Hong Jae Jeon, Hei Gwon Choi, In Sun Kwon, Woo Sun Rou, Jeong Eun Lee, Tae Hee Lee, Seok Hyun Kim, Byung Seok Lee, Kyung Sook Shin, Hyun Jung Lee, Hyuk Soo Eun
BMC Gastroenterology.2023;[Epub]     CrossRef
The Association of Nonalcoholic Fatty Liver Disease With Neutrophil-to-Lymphocyte Ratio and Neutrophil-Percentage-to-Albumin Ratio
Dragoș Constantin Cucoranu, Marian Pop, Raluca Niculescu, Irina-Bianca Kosovski, Radu-Ovidiu Toganel, Razvan-Andrei Licu, Anca Bacârea
Cureus.2023;[Epub]     CrossRef
Regression of nonalcoholic fatty liver disease is associated with reduced risk of incident diabetes: A longitudinal cohort study
Dong Hyun Sinn, Danbee Kang, Eliseo Guallar, Sung Chul Choi, Yun Soo Hong, Yewan Park, Juhee Cho, Geum-Youn Gwak, Ahmed Mustafa Rashid
PLOS ONE.2023; 18(7): e0288820.     CrossRef
Correcting statistical CT number biases without access to raw detector counts: Applications to high spatial resolution photon counting CT imaging
Dalton Griner, Nikou Lei, Guang‐Hong Chen, Ke Li
Medical Physics.2023; 50(10): 6022.     CrossRef
The imaging techniques and diagnostic performance of ultrasound, CT, and MRI in detecting liver steatosis and fat quantification: A systematic review
Yulei Wan, Dawei Wang, Hongbo Li, Ying Xu
Journal of Radiation Research and Applied Sciences.2023; 16(4): 100658.     CrossRef
NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES: MODERN IMAGING MODALITIES
A. Yu. Babenko, M. Yu. Laevskaya, A. R. Meltonian, Yu. N. Savchenkov, G. E. Trufanov
Translational Medicine.2023; 10(3): 146.     CrossRef
Accuracy of attenuation coefficient measurement (ACM) for real-time ultrasound hepatic steatometry: Comparison of simulator/phantom data with magnetic resonance imaging proton density fat fraction (MRI-PDFF)
Nazarii Kobyliak, Oleh Dynnyk, Maryana Savytska, Oleksandr Solodovnyk, Oleksandr Zakomornyi, Oleksii Оmеlchenko, Anton Kushnir, Roman Titorenko
Heliyon.2023; 9(10): e20642.     CrossRef
CT-based measurement of visceral adipose tissue volume as a reliable tool for assessing metabolic risk factors in prediabetes across subtypes
Jihyun Kim, Keunyoung Kim
Scientific Reports.2023;[Epub]     CrossRef
The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
Teodora Biciusca, Sorina Ionelia Stan, Mara Amalia Balteanu, Ramona Cioboata, Alice Elena Ghenea, Suzana Danoiu, Ana-Maria Bumbea, Viorel Biciusca
Diagnostics.2023; 13(21): 3316.     CrossRef
Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
Kamlesh K. Bhopale, Mukund P. Srinivasan
Livers.2023; 3(4): 597.     CrossRef
Non-Invasive Diagnostic of NAFLD in Type 2 Diabetes Mellitus and Risk Stratification: Strengths and Limitations
Alina Boeriu, Daniela Dobru, Crina Fofiu
Life.2023; 13(12): 2262.     CrossRef
Advanced liver fibrosis measured by transient elastography predicts chronic kidney disease development in individuals with non-alcoholic fatty liver disease
Chan-Young Jung, Geun Woo Ryu, Hyung Woo Kim, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
Diabetologia.2022; 65(3): 518.     CrossRef
The reliability of CT numbers as absolute values for diagnostic scanning, dental imaging, and radiation therapy simulation: A narrative review
Yazan Al-Hayek, Kelly Spuur, Xiaoming Zheng, Christopher Hayre, Rob Davidson
Journal of Medical Imaging and Radiation Sciences.2022; 53(1): 138.     CrossRef
Comparison of bioelectrical impedance analysis, mass index, and waist circumference in assessing risk for non-alcoholic steatohepatitis
Katherine J.P. Schwenger, Alexander Kiu, Maryam AlAli, Amnah Alhanaee, Sandra E. Fischer, Johane P. Allard
Nutrition.2022; 93: 111491.     CrossRef
Biochemical and Radiological Changes in Liver Steatosis Following Mifepristone Treatment in Patients With Hypercortisolism
John C. Parker, Andreas G. Moraitis, Joseph K. Belanoff
AACE Clinical Case Reports.2022; 8(1): 25.     CrossRef
The effect of dietary patterns on non-alcoholic fatty liver disease diagnosed by biopsy or magnetic resonance in adults: a systematic review of randomised controlled trials
Angeliki M. Angelidi, Angeliki Papadaki, Eric Nolen-Doerr, Chrysoula Boutari, Christos S. Mantzoros
Metabolism.2022; 129: 155136.     CrossRef
Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
Eirini Martinou, Marinos Pericleous, Irena Stefanova, Vasha Kaur, Angeliki M. Angelidi
Diagnostics.2022; 12(2): 407.     CrossRef
Assessment of Liver Fat: Dual-Energy CT versus Conventional CT with and without Contrast
Jack Junchi Xu, Mikkel Ranum Boesen, Sofie Lindskov Hansen, Peter Sommer Ulriksen, Søren Holm, Lars Lönn, Kristoffer Lindskov Hansen
Diagnostics.2022; 12(3): 708.     CrossRef
Noninvasive assessment of hepatic steatosis using a pathologic reference standard: comparison of CT, MRI, and US-based techniques
Jae Seok Bae, Dong Ho Lee, Kyung-Suk Suh, Haeryoung Kim, Kyung Bun Lee, Jae Young Lee, Joon Koo Han
Ultrasonography.2022; 41(2): 344.     CrossRef
Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study
Dong Hyun Sinn, Danbee Kang, Mira Kang, Eliseo Guallar, Yun Soo Hong, Kyung Hyun Lee, Jiyeon Park, Juhee Cho, Geum‐Youn Gwak
Hepatology.2022; 76(6): 1746.     CrossRef
Quantification of lipid droplets polarity for evaluating non-alcoholic fatty liver disease via fluorescence lifetime imaging
Chaofeng Lai, Yuping Zhao, Xiang Zou, Yun Liang, Weiying Lin
Sensors and Actuators B: Chemical.2022; 369: 132267.     CrossRef
Nonalcoholic fatty liver disease and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
Sara Karjoo, Anthony Auriemma, Teresa Fraker, Harold Edward Bays
Obesity Pillars.2022; 3: 100027.     CrossRef
Artificial intelligence in liver ultrasound
Liu-Liu Cao, Mei Peng, Xiang Xie, Gong-Quan Chen, Shu-Yan Huang, Jia-Yu Wang, Fan Jiang, Xin-Wu Cui, Christoph F Dietrich
World Journal of Gastroenterology.2022; 28(27): 3398.     CrossRef
Triglycerides to high-density lipoprotein cholesterol ratio for diagnosing nonalcoholic fatty liver disease
Roberto CATANZARO, Federica SELVAGGIO, Morena SCIUTO, Luca ZANOLI, Azam YAZDANI, Fang HE, Francesco MAROTTA
Minerva Gastroenterology.2022;[Epub]     CrossRef
Association between severe hepatic steatosis examined by Fibroscan and the risk of high-risk colorectal neoplasia
Kwang Woo Kim, Hyoun Woo Kang, Hosun Yoo, Yukyung Jun, Hyun Jung Lee, Jong Pil Im, Ji Won Kim, Joo Sung Kim, Seong-Joon Koh, Yong Jin Jung, Atsushi Hosui
PLOS ONE.2022; 17(12): e0279242.     CrossRef
Effect of focused ultrasound cavitation augmented with aerobic exercise on abdominal and intrahepatic fat in patients with non-alcoholic fatty liver disease: A randomized controlled trial
Mona Mohamed Taha, Yasser M. Aneis, Heba Mohamed Mohamady, Alrasheedy S. A., Shereen Hamed Elsayed, Wan-Long Chuang
PLOS ONE.2021; 16(4): e0250337.     CrossRef
Seeing the fetus from a DOHaD perspective: discussion paper from the advanced imaging techniques of DOHaD applications workshop held at the 2019 DOHaD World Congress
Janna L. Morrison, Oyekoya T. Ayonrinde, Alison S. Care, Geoffrey D. Clarke, Jack R.T. Darby, Anna L. David, Justin M. Dean, Stuart B. Hooper, Marcus J. Kitchen, Christopher K. Macgowan, Andrew Melbourne, Erin V McGillick, Charles A. McKenzie, Navin Micha
Journal of Developmental Origins of Health and Disease.2021; 12(2): 153.     CrossRef
Quantification of Liver Fat by MRI-PDFF Imaging in Patients with Suspected Non-alcoholic Fatty Liver Disease and Its Correlation with Metabolic Syndrome, Liver Function Test and Ultrasonography
Gajanan A. Rodge, Mahesh K. Goenka, Usha Goenka, Shivaraj Afzalpurkar, Bhavik B. Shah
Journal of Clinical and Experimental Hepatology.2021; 11(5): 586.     CrossRef
MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy
Ying-Xin Xian, Jian-Ping Weng, Fen Xu
Chinese Medical Journal.2021; 134(1): 8.     CrossRef
Diagnosis of fatty liver disease by a multiphoton-active and lipid-droplet-specific AIEgen with nonaromatic rotors
Hojeong Park, Shijie Li, Guangle Niu, Haoke Zhang, Zhuoyue Song, Qing Lu, Jun Zhang, Chao Ma, Ryan T. K. Kwok, Jacky W. Y. Lam, Kam Sing Wong, Xiaoqiang Yu, Qingping Xiong, Ben Zhong Tang
Materials Chemistry Frontiers.2021; 5(4): 1853.     CrossRef
Association of Hepatic Steatosis Index with Nonalcoholic Fatty Liver Disease Diagnosed by Non-Enhanced CT in a Screening Population
Jieun Chung, Hee-Sun Park, Young-Jun Kim, Mi-Hye Yu, Sungeun Park, Sung-Il Jung
Diagnostics.2021; 11(12): 2168.     CrossRef
Quantitative Assessment of Fatty Liver using Ultrasound with Normalized Local Variance Technique
Jae Seok Bae, Dong Ho Lee, Jae Young Lee, Haeryoung Kim, Su Jong Yu, Jeong-Hoon Lee, Eun Ju Cho, Yun Bin Lee, Joon Koo Han, Byung Ihn Choi
Ultraschall in der Medizin - European Journal of Ultrasound.2021; 42(06): 599.     CrossRef
Quantitative assessment of fatty liver using ultrasound attenuation imaging
Dong Ho Lee
Journal of Medical Ultrasonics.2021; 48(4): 465.     CrossRef
Ten things to know about ten imaging studies: A preventive cardiology perspective (“ASPC top ten imaging”)
Harold E. Bays, Amit Khera, Michael J. Blaha, Matthew J Budoff, Peter P. Toth
American Journal of Preventive Cardiology.2021; 6: 100176.     CrossRef
Magnetic Resonance Spectroscopy of Hepatic Fat from Fundamental to Clinical Applications
Duanghathai Pasanta, Khin Thandar Htun, Jie Pan, Montree Tungjai, Siriprapa Kaewjaeng, Hongjoo Kim, Jakrapong Kaewkhao, Suchart Kothan
Diagnostics.2021; 11(5): 842.     CrossRef
Cascaded Deep Learning Neural Network for Automated Liver Steatosis Diagnosis Using Ultrasound Images
Se-Yeol Rhyou, Jae-Chern Yoo
Sensors.2021; 21(16): 5304.     CrossRef
Quantification of Liver Fat Content with Ultrasound: A WFUMB Position Paper
Giovanna Ferraioli, Annalisa Berzigotti, Richard G. Barr, Byung I. Choi, Xin Wu Cui, Yi Dong, Odd Helge Gilja, Jae Young Lee, Dong Ho Lee, Fuminori Moriyasu, Fabio Piscaglia, Katsutoshi Sugimoto, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Christoph F. Die
Ultrasound in Medicine & Biology.2021; 47(10): 2803.     CrossRef
Ultrasound Stratification of Hepatic Steatosis Using Hepatorenal Index
Stephen I. Johnson, Daniel Fort, Kenneth J. Shortt, George Therapondos, Gretchen E. Galliano, Theresa Nguyen, Edward I. Bluth
Diagnostics.2021; 11(8): 1443.     CrossRef
Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications
T. Hydes, E. Brown, A. Hamid, A.C. Bateman, D.J. Cuthbertson
Clinical Therapeutics.2021; 43(9): 1505.     CrossRef
Body composition, phenotype and central obesity indices in Egyptian women with non-alcoholic fatty liver disease
Moushira Zaki, Darine Amin, Ramy Mohamed
Journal of Complementary and Integrative Medicine.2021; 18(2): 385.     CrossRef
The prevalence of gestational diabetes mellitus in women diagnosed with non-alcoholic fatty liver disease during pregnancy: A systematic review and meta-analysis
Thora Ying Li Chai, Romesh Mark Rajaratnam, Difei Deng, Jacob George, Dharmintra Pasupathy, Ngai Wah Cheung
Journal of Diabetes and its Complications.2021; 35(9): 107991.     CrossRef
Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease
Monica Lupsor-Platon, Teodora Serban, Alexandra Iulia Silion, George Razvan Tirpe, Alexandru Tirpe, Mira Florea
Cancers.2021; 13(4): 790.     CrossRef
Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease
Dong Hyun Sinn, Danbee Kang, Soo Jin Cho, Seung Woon Paik, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
European Journal of Gastroenterology & Hepatology.2021; 33(1S): e529.     CrossRef
Circulatory microRNAs as potential biomarkers for fatty liver disease: the Rotterdam study
Xiaofang Zhang, Michelle M. J. Mens, Yasir J. Abozaid, Daniel Bos, Sarwa Darwish Murad, Robert J. de Knegt, M. Arfan Ikram, Qiuwei Pan, Mohsen Ghanbari
Alimentary Pharmacology & Therapeutics.2021; 53(3): 432.     CrossRef
Liver steatosis in adult patients on home parenteral nutrition
Taja Jordan, Peter Popovič, Nada Rotovnik Kozjek
European Journal of Clinical Nutrition.2020; 74(2): 255.     CrossRef
Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV‐monoinfected patients
G Sebastiani, S Cocciolillo, G Mazzola, A Malagoli, J Falutz, A Cervo, S Petta, T Pembroke, P Ghali, G Besutti, I Franconi, J Milic, A Cascio, G Guaraldi
HIV Medicine.2020; 21(2): 96.     CrossRef
Non‐alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study
Dong Hyun Sinn, Danbee Kang, Yoosoo Chang, Seungho Ryu, Soo Jin Cho, Seung Woon Paik, Young Bin Song, Roberto Pastor‐Barriuso, Eliseo Guallar, Juhee Cho, Geum‐Youn Gwak
Journal of Gastroenterology and Hepatology.2020; 35(5): 833.     CrossRef
Quantification of hepatic steatosis in histologic images by deep learning method
Fan Yang, Xianyuan Jia, Pinggui Lei, Yan He, Yining Xiang, Jun Jiao, Shi Zhou, Wei Qian, Qinghong Duan
Journal of X-Ray Science and Technology.2020; 27(6): 1033.     CrossRef
Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study
Jeong-Ju Yoo, Yang Jae Yoo, Woo Ram Moon, Seung Up Kim, Soung Won Jeong, Ha Na Park, Min Gyu Park, Jae Young Jang, Su Yeon Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Sang Gyune Kim, Young Seok Kim, Ji Hoon Kim, Jong
The Korean Journal of Internal Medicine.2020; 35(6): 1346.     CrossRef
Non-invasive monitoring of hepatic steatosis via acoustic structure quantification of ultrasonography with MR spectroscopy as the reference standard
Dong Ho Lee, Jae Young Lee, Min Sun Park, Joon Koo Han
Ultrasonography.2020; 39(1): 70.     CrossRef
Work up of fatty liver by primary care physicians, review
Rishi Rikhi, Tavankit Singh, Jamak Modaresi Esfeh
Annals of Medicine and Surgery.2020; 50: 41.     CrossRef
Development and Validation of a Simple Index Based on Non-Enhanced CT and Clinical Factors for Prediction of Non-Alcoholic Fatty Liver Disease
Yura Ahn, Sung-Cheol Yun, Seung Soo Lee, Jung Hee Son, Sora Jo, Jieun Byun, Yu Sub Sung, Ho Sung Kim, Eun Sil Yu
Korean Journal of Radiology.2020; 21(4): 413.     CrossRef
Diagnostic accuracy of B-Mode ultrasound and Hepatorenal Index for graduation of hepatic steatosis in patients with chronic liver disease
Golo Petzold, Julian Lasser, Janina Rühl, Sebastian C. B. Bremer, Richard F. Knoop, Volker Ellenrieder, Steffen Kunsch, Albrecht Neesse, Pavel Strnad
PLOS ONE.2020; 15(5): e0231044.     CrossRef
Accuracy of a Semi-Quantitative Ultrasound Method to Determine Liver Fat Infiltration in Early Adulthood
Camila Ibacahe, Paulina Correa-Burrows, Raquel Burrows, Gladys Barrera, Elissa Kim, Sandra Hirsch, Boris Jofré, Estela Blanco, Sheila Gahagan, Daniel Bunout
Diagnostics.2020; 10(6): 431.     CrossRef
Radiologic Nonalcoholic Fatty Liver Disease Increases the Risk of Hepatocellular Carcinoma in Patients With Suppressed Chronic Hepatitis B
Hyeki Cho, Young Chang, Jeong-Hoon Lee, Young Youn Cho, Joon Yeul Nam, Yun Bin Lee, Dong Ho Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jeong Min Lee, Jung-Hwan Yoon
Journal of Clinical Gastroenterology.2020; 54(7): 633.     CrossRef
Alteration of Serum Phospholipid n‐6 Polyunsaturated Fatty Acid Compositions in Nonalcoholic Fatty Liver Disease in the Japanese Population: A Cross‐Sectional Study
Zhe Jiang, Takuya Hayashi, Kentaro Kashima, Kayo Kurotani, Bungo Shirouchi, Tetsuya Mizoue, Masao Sato
Lipids.2020; 55(6): 599.     CrossRef
Association between Inflammatory Biomarkers and Nutritional Status in Fatty Liver
Hee-Sook Lim, Joungyun Choi, Bora Lee, Sang Gyune Kim, Young Seok Kim, Jeong-Ju Yoo
Clinical Nutrition Research.2020; 9(3): 182.     CrossRef
Use of imaging techniques for non-invasive assessment in the diagnosis and staging of non-alcoholic fatty liver disease
Luca Miele, Maria A. Zocco, Fabrizio Pizzolante, Nicoletta De Matthaeis, Maria E. Ainora, Antonio Liguori, Antonio Gasbarrini, Antonio Grieco, Gianludovico Rapaccini
Metabolism.2020; 112: 154355.     CrossRef
Impact of Androgen Deprivation Therapy on Non-Alcoholic Fatty Liver Disease in Patients with Prostate Cancer: A CT Evaluation
Harutake Sawazaki, Yosuke Kitamura, Kota Yagi, Yuichi Arai
Urologia Internationalis.2020; 104(5-6): 425.     CrossRef
Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
David Sooik Kim, Mi Young Jeon, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
Clinical and Molecular Hepatology.2019; 25(3): 283.     CrossRef
Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects
Yeojun Yun, Han-Na Kim, Eun-ju Lee, Seungho Ryu, Yoosoo Chang, Hocheol Shin, Hyung-Lae Kim, Tae Hun Kim, Kwon Yoo, Hwi Young Kim, Ming-Lung Yu
PLOS ONE.2019; 14(3): e0213692.     CrossRef
Can Nonfibrotic Nonalcoholic Steatohepatitis Be Effectively Identified by Supersonic Shear Imaging?
Jiajia Yang, Liwu Lin, Ensheng Xue, Dengke Hong, Yan Yang, Meifang Xu, Zhikui Chen
Analytical Cellular Pathology.2019; 2019: 1.     CrossRef
A gathering storm
Nitin Kapoor, Jennifer Audsley, Priscilla Rupali, Joe Sasadeusz, Thomas V. Paul, Nihal Thomas, Sharon R. Lewin
AIDS.2019; 33(7): 1105.     CrossRef
Assessment of hepatic steatosis by using attenuation imaging: a quantitative, easy-to-perform ultrasound technique
Jae Seok Bae, Dong Ho Lee, Jae Young Lee, Haeryoung Kim, Su Jong Yu, Jeong-Hoon Lee, Eun Ju Cho, Yun Bin Lee, Joon Koo Han, Byung Ihn Choi
European Radiology.2019; 29(12): 6499.     CrossRef
Augmented intelligence with natural language processing applied to electronic health records for identifying patients with non-alcoholic fatty liver disease at risk for disease progression
Tielman T. Van Vleck, Lili Chan, Steven G. Coca, Catherine K. Craven, Ron Do, Stephen B. Ellis, Joseph L. Kannry, Ruth J.F. Loos, Peter A. Bonis, Judy Cho, Girish N. Nadkarni
International Journal of Medical Informatics.2019; 129: 334.     CrossRef
How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
Jung Hwan Yu, Jin-Woo Lee
Clinical and Molecular Hepatology.2019; 25(3): 280.     CrossRef
Underlying nonalcoholic fatty liver disease is a significant factor for breast cancer recurrence after curative surgery
Young-Sun Lee, Ha Seok Lee, Sung Won Chang, Chan Uk Lee, Jung Sun Kim, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Chang Hee Lee, Sang Uk Woo, Jae Hong Seo, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun
Medicine.2019; 98(39): e17277.     CrossRef
Examining the associations among intraocular pressure, hepatic steatosis, and anthropometric parameters
Ying-Jen Chen, Jiann-Torng Chen, Ming-Cheng Tai, Chang-Min Liang, Yuan-Yuei Chen, Tung-Wei Kao, Wen-Hui Fang, Wei-Liang Chen
Medicine.2019; 98(43): e17598.     CrossRef
Quantification of Liver Fat in NAFLD: Available Modalities and Clinical Significance
Kee-Huat Chuah, Wah-Kheong Chan
Current Hepatology Reports.2019; 18(4): 492.     CrossRef
Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis
Jia-Zhen Zhang, Jing-Jing Cai, Yao Yu, Zhi-Gang She, Hongliang Li
Gene Expression.2019; 19(3): 187.     CrossRef
Prevalence and predictive factors of moderate/severe liver steatosis in chronic hepatitis C (CHC) infected patients evaluated with controlled attenuation parameter (CAP)
A. C. Cardoso, R. M. Perez, C. de Figueiredo‐Mendes, N. Carvalho Leite, H. S. Moraes‐Coelho, C. A. Villela‐Nogueira
Journal of Viral Hepatitis.2018; 25(11): 1244.     CrossRef
Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Alessandro Mantovani, Fabio Nascimbeni, Amedeo Lonardo, Giacomo Zoppini, Enzo Bonora, Christos S. Mantzoros, Giovanni Targher
Thyroid.2018; 28(10): 1270.     CrossRef
EVALUATION OF LIPID CONTENT IN PATIENTS WITH LIVER STEATOSIS AND STEATOHEPATITIS USING PROTON MR-SPECTROSCOPY
S. K. Ternovoy, G. A. Shiryaev, D. V. Ustyuzhanin, D. T. Abdurakhmanov
Medical Visualization.2018; (4): 50.     CrossRef